Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents

Scandinavian Journal of Primary Health Care

Volumn 28, Issue 3, 2010, Pages 154-159

  Teramura Grönblad, Mariko ^a   Hosia Randell, Helka ^b   Muurinen, Seija ^a   Pitkala, Kaisu ^b  

^a Helsinki City Health Department   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aged; Diarrhea; Family practice; Hip fracture; Proton pump inhibitors; Risks

Indexed keywords

PROTON PUMP INHIBITOR;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; COMORBIDITY; CONSTIPATION; CROSS-SECTIONAL STUDY; DIARRHEA; FEMALE; FRAIL ELDERLY; HIP FRACTURE; HUMAN; MALE; NURSING HOME; POLYPHARMACY; RISK FACTOR; TIME; VOMITING;

AGED; AGED, 80 AND OVER; COMORBIDITY; CONSTIPATION; CROSS-SECTIONAL STUDIES; DIARRHEA; FEMALE; FRAIL ELDERLY; HIP FRACTURES; HUMANS; MALE; NURSING HOMES; POLYPHARMACY; PROTON PUMP INHIBITORS; RISK FACTORS; TIME FACTORS; VOMITING;

EID: 77955500316     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.3109/02813432.2010.493315     Document Type: Article

References (29)

1. Wolfe MM, Sachs G. Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal refl ux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118(Suppl.1):9-31.
2. Barrison AF, Jarboe LA, Weinberg BM, Nimmagadda K, Sullivan LM, Wolfe MM. Patterns of proton pump inhibitor use in clinical practice. Am J Med 2001;111:469-473
3. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, et al. A comparison of fi ve maintenance therapies for refl ux esophagitis. N Engl J Med 1995;111: 469-473
4. Salas M, Ward A, Caro J. Are proton pump inhibitors the fi rst choice for acute treatment of gastric ulcers? A meta-analysis of randomized clinical trials. BMC Gastroenterol 2002;2:17.
5. Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I. Prevention of gastrointestinal damage with omeprazole in patients receiving continuous NSAIDs treatment: A double blind placebo controlled study. Ital J Gastroenterol Hepatol 1998;30:43-47
6. Armstrong D, Marshall JK, Chiba N, Enns R, Fallone CA, Fass R, et al. Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal refl ux disease in adults-update 2004. Can J Gastroenterol 2005;19:15-35.
7. Dries AM, Richardson P, Cavazos J, Abraham NS. Therapeutic intent of proton pump inhibitor prescription among elderly nonsteroidal anti-infl ammatory drug users. Aliment Pharmacol Ther 2009;30:652-661
8. Garnett WR. Considerations for long-term use of proton-pump inhibitors. Am J Health Syst Pharm 1998;55: 2268-2279
9. Leonard J, Marshall JK, Moayyedi P. Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007;102:2047-2056
10. Laheij RJ, Sturkenbloom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-1960
11. Yearsley KA, Gilby LG, Ramadas AV Kubiak EM, Fone DL, Allison MC. Proton pump inhibitor therapy is a risk factor for Clostridium diffi cile-associated diarrhoea. Aliment Pharmacol Ther 2006;24:613-619
12. Yang Y-X, Lewis JD, Epstein S, Melz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006;296:2947-2953
13. Moayyedi P, Cranney A. Hip fracture and proton pump inhibitor therapy: Balancing the evidence for benefi t and harm. Am J Gastroenterol 2008;103:2428-2431
14. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Int Med 1995;123:195-204.
15. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49:200-209
16. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004;79:122-139
17. Suominen M, Muurinen S, Routasalo P, Soini H, Suur-Uski I, Peiponen A, et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 2005;59:578-583
18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40:373-383
19. Vellas BJ, Guigoz Y, Garry PJ. Facts, research and inter vention in geriatrics: Nutrition in the elderly. The Mini Nutritional Assessment (MNA). 3rd ed. Paris: Serdi Publishing; 1997.
20. Hosia-Randell H, Suominen M, Muurinen S, Pitkälä KH. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging 2007;24:147-154
21. Moayyedi P, Talley NJ. Gastro-oesophageal refl ux disease. Lancet 2006;367:2086-3000.
22. Maton P. Omeprazole administration as a model for atrophic gastritis. In: Holt P, Russell R, editors. Chronic gastritis and hypochlorhydria in the elderly. Boca Raton,FL: CRC; 1993. p 115-126
23. Saltzman JR, Kowdley KV, Pedrosa MC, Sepe T, Golner B, Perrone G, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastro-enterology 1994;106:615-623
24. Badenoch J, Bedford P. Massive diverticulosis of the upper intestine presenting with steatorrhea and megaloblastic anemia. Q J Med 1954;23:462-463
25. Dyspepsia: managing dyspepsia in adults in primary care. Available at: http://www.nice.org.uk/nicemedia/pdf/CG017fullguideline.pdf (accessed 24 February 2009).
26. Choudhry MN, Soran H, Ziglam HM. Overuse and inappropriate prescribing of proton pump inhibitors in patients with clostridium diffi cile-associated disease. Q J Med 2008; 101:445-448
27. Chonan O, Takahashi R, Yasui H, Watanuki M. Effect of L-lactic acid on calcium absorption in rats fed omeprazole. J Nutr Sci Vitaminol 1998:44:473-481 (Pubitemid 28370958)
28. O'Connel MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial. Am J Med 2005;118:778-781
29. Zwisler JE, Larsen J, Gram LF. When to stop? Scand J Prim Health Care 2005;27:1-3.